I am Jules Wendon from King's College Hospital in London. I was talking today about the role of albumin. Albumin seems to have a significant benefit in the management of patients with liver disease. Essentially, there are different roles for albumin. It has a role in liver disease, without question, particularly in the prevention of hepatorenal failure. More interestingly, it also has marked inflammatory and anti-inflammatory capacity, and I think increasingly we will see a role for albumin in sepsis, where it seems to have a beneficial effect in terms of outcomes and mortality, as shown in meta-analyses looking at immune function.